Literature DB >> 32723158

Initial changes in neuropsychologists clinical practice during the COVID-19 pandemic: A survey study.

David E Marra1, James B Hoelzle2, Jeremy J Davis3, Eben S Schwartz2.   

Abstract

Objective: In light of the COVID-19 pandemic, a majority of clinicians have had to quickly and dramatically alter their clinical practices. Two surveys were administered on 3/26/2020 and 3/30/2020, respectively, to document immediate changes and challenges in clinical practice.Method: Two surveys were administered between 3/26/2020 and 3/30/2020, via SurveyMonkey and Google Forms, asking clinicians questions pertaining to practice issues during the early stages of the COVID-19 pandemic. Quantitative responses from the second survey were stratified by clinical setting (Medical Hospital vs. Private Practice) prior to analysis. Qualitative, free-response items were coded by the authors to better understand immediate changes in practice and other concerns.
Results: 266 neuropsychologists completed Survey 1 and 230 completed Survey 2. Results suggest that practices immediately moved towards remote service provision. A meaningful proportion of clinicians and their staff were immediately affected economically by the pandemic, with clinicians in private practice differentially affected. Furthermore, a small but significant minority of respondents faced ethical dilemmas related to service provision and expressed concerns with initial communication from their employment organizations. Respondents requested clear best-practice guidelines from neuropsychological practice organizations.Conclusions: It is clear that field of neuropsychology has drastically shifted clinical practices in response to COVID-19 and is likely to continue to evolve. While these responses were collected in the early stages of stay-at-home orders, policy changes continue to occur and it is paramount that practice organizations consider the initial challenges expressed by clinicians when formulating practice recommendations and evaluating the clinical utility of telehealth services.

Entities:  

Keywords:  COVID-19; clinical practice; neuropsychology; practice survey

Mesh:

Year:  2020        PMID: 32723158     DOI: 10.1080/13854046.2020.1800098

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  6 in total

1.  The TestMyBrain Digital Neuropsychology Toolkit: Development and Psychometric Characteristics.

Authors:  Shifali Singh; Roger W Strong; Laneé Jung; Frances Haofei Li; Liz Grinspoon; Luke S Scheuer; Eliza J Passell; Paolo Martini; Naomi Chaytor; Jason R Soble; Laura Germine
Journal:  J Clin Exp Neuropsychol       Date:  2021-12-15       Impact factor: 2.475

2.  Neuropsychologists' practice adjustments: The impact of COVID-19.

Authors:  Katherine L Zane; Nicholas S Thaler; Shannon E Reilly; James J Mahoney; David M Scarisbrick
Journal:  Clin Neuropsychol       Date:  2020-12-28       Impact factor: 3.535

3.  The Wisconsin Card Sorting Test: Split-Half Reliability Estimates for a Self-Administered Computerized Variant.

Authors:  Alexander Steinke; Bruno Kopp; Florian Lange
Journal:  Brain Sci       Date:  2021-04-21

4.  Identifying response and predictive biomarkers for Transcranial magnetic stimulation outcomes: protocol and rationale for a mechanistic study of functional neuroimaging and behavioral biomarkers in veterans with Pharmacoresistant depression.

Authors:  Leanne M Williams; John T Coman; Patrick C Stetz; Nicole C Walker; F Andrew Kozel; Mark S George; Jong Yoon; Laura M Hack; Michelle R Madore; Kelvin O Lim; Noah S Philip; Paul E Holtzheimer
Journal:  BMC Psychiatry       Date:  2021-01-13       Impact factor: 3.630

5.  Monitoring Strategies and Intervention Policies for the Enhancement and Protection of Advanced Neuroscientific Research Post COVID-19 in Italy: Preliminary Evidence.

Authors:  Michela Balconi; Marco Bove; Maurizio Bossola; Laura Angioletti; Giulia Fronda; Davide Crivelli
Journal:  Front Public Health       Date:  2021-11-25

Review 6.  Managing medicines in the time of COVID-19: implications for community-dwelling people with dementia.

Authors:  Heather E Barry; Carmel M Hughes
Journal:  Int J Clin Pharm       Date:  2020-08-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.